COVID-19 Impact on Global Pemphigus Vulgaris Treatment Market Size, Status and Forecast 2020-2026
![](/report_cover/6975/covid-19-impact-on-global-pemphigus-vulgaris-treatment-market-size-status-n-forecast-2020-2026_en.gif)
This report focuses on the global Pemphigus Vulgaris Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pemphigus Vulgaris Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
The key players covered in this study
- Roche
- Novartis
- GlaxoSmithKline
- Mylan
- Genentech
- Principia Biopharma
- Argenx
- Alexion
- Vifor Pharma
- Oral
- Injectable
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- North America
- Europe
- China
- Japan
- Southeast Asia
- India
- Central & South America
- To analyze global Pemphigus Vulgaris Treatment status, future forecast, growth opportunity, key market and key players.
- To present the Pemphigus Vulgaris Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
- To strategically profile the key players and comprehensively analyze their development plan and strategies.
- To define, describe and forecast the market by type, market and key regions.
- History Year: 2015-2019
- Base Year: 2019
- Estimated Year: 2020
- Forecast Year 2020 to 2026
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pemphigus Vulgaris Treatment Revenue
1.4 Market Analysis by Type
1.4.1 Global Pemphigus Vulgaris Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oral
1.4.3 Injectable
1.5 Market by Application
1.5.1 Global Pemphigus Vulgaris Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Pemphigus Vulgaris Treatment Industry Impact
1.6.1 How the Covid-19 is Affecting the Pemphigus Vulgaris Treatment Industry
1.6.1.1 Pemphigus Vulgaris Treatment Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Pemphigus Vulgaris Treatment Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Pemphigus Vulgaris Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Pemphigus Vulgaris Treatment Market Perspective (2015-2026)
2.2 Pemphigus Vulgaris Treatment Growth Trends by Regions
2.2.1 Pemphigus Vulgaris Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pemphigus Vulgaris Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Pemphigus Vulgaris Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Pemphigus Vulgaris Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Pemphigus Vulgaris Treatment Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Pemphigus Vulgaris Treatment Players by Market Size
3.1.1 Global Top Pemphigus Vulgaris Treatment Players by Revenue (2015-2020)
3.1.2 Global Pemphigus Vulgaris Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Pemphigus Vulgaris Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pemphigus Vulgaris Treatment Market Concentration Ratio
3.2.1 Global Pemphigus Vulgaris Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pemphigus Vulgaris Treatment Revenue in 2019
3.3 Pemphigus Vulgaris Treatment Key Players Head office and Area Served
3.4 Key Players Pemphigus Vulgaris Treatment Product Solution and Service
3.5 Date of Enter into Pemphigus Vulgaris Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Pemphigus Vulgaris Treatment Historic Market Size by Type (2015-2020)
4.2 Global Pemphigus Vulgaris Treatment Forecasted Market Size by Type (2021-2026)
5 PEMPHIGUS VULGARIS TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Pemphigus Vulgaris Treatment Market Size by Application (2015-2020)
5.2 Global Pemphigus Vulgaris Treatment Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Pemphigus Vulgaris Treatment Market Size (2015-2020)
6.2 Pemphigus Vulgaris Treatment Key Players in North America (2019-2020)
6.3 North America Pemphigus Vulgaris Treatment Market Size by Type (2015-2020)
6.4 North America Pemphigus Vulgaris Treatment Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Pemphigus Vulgaris Treatment Market Size (2015-2020)
7.2 Pemphigus Vulgaris Treatment Key Players in Europe (2019-2020)
7.3 Europe Pemphigus Vulgaris Treatment Market Size by Type (2015-2020)
7.4 Europe Pemphigus Vulgaris Treatment Market Size by Application (2015-2020)
8 CHINA
8.1 China Pemphigus Vulgaris Treatment Market Size (2015-2020)
8.2 Pemphigus Vulgaris Treatment Key Players in China (2019-2020)
8.3 China Pemphigus Vulgaris Treatment Market Size by Type (2015-2020)
8.4 China Pemphigus Vulgaris Treatment Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Pemphigus Vulgaris Treatment Market Size (2015-2020)
9.2 Pemphigus Vulgaris Treatment Key Players in Japan (2019-2020)
9.3 Japan Pemphigus Vulgaris Treatment Market Size by Type (2015-2020)
9.4 Japan Pemphigus Vulgaris Treatment Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Pemphigus Vulgaris Treatment Market Size (2015-2020)
10.2 Pemphigus Vulgaris Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pemphigus Vulgaris Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Pemphigus Vulgaris Treatment Market Size by Application (2015-2020)
11 INDIA
11.1 India Pemphigus Vulgaris Treatment Market Size (2015-2020)
11.2 Pemphigus Vulgaris Treatment Key Players in India (2019-2020)
11.3 India Pemphigus Vulgaris Treatment Market Size by Type (2015-2020)
11.4 India Pemphigus Vulgaris Treatment Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Pemphigus Vulgaris Treatment Market Size (2015-2020)
12.2 Pemphigus Vulgaris Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Pemphigus Vulgaris Treatment Market Size by Type (2015-2020)
12.4 Central & South America Pemphigus Vulgaris Treatment Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Roche
13.1.1 Roche Company Details
13.1.2 Roche Business Overview and Its Total Revenue
13.1.3 Roche Pemphigus Vulgaris Treatment Introduction
13.1.4 Roche Revenue in Pemphigus Vulgaris Treatment Business (2015-2020))
13.1.5 Roche Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview and Its Total Revenue
13.2.3 Novartis Pemphigus Vulgaris Treatment Introduction
13.2.4 Novartis Revenue in Pemphigus Vulgaris Treatment Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 GlaxoSmithKline
13.3.1 GlaxoSmithKline Company Details
13.3.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.3.3 GlaxoSmithKline Pemphigus Vulgaris Treatment Introduction
13.3.4 GlaxoSmithKline Revenue in Pemphigus Vulgaris Treatment Business (2015-2020)
13.3.5 GlaxoSmithKline Recent Development
13.4 Mylan
13.4.1 Mylan Company Details
13.4.2 Mylan Business Overview and Its Total Revenue
13.4.3 Mylan Pemphigus Vulgaris Treatment Introduction
13.4.4 Mylan Revenue in Pemphigus Vulgaris Treatment Business (2015-2020)
13.4.5 Mylan Recent Development
13.5 Genentech
13.5.1 Genentech Company Details
13.5.2 Genentech Business Overview and Its Total Revenue
13.5.3 Genentech Pemphigus Vulgaris Treatment Introduction
13.5.4 Genentech Revenue in Pemphigus Vulgaris Treatment Business (2015-2020)
13.5.5 Genentech Recent Development
13.6 Principia Biopharma
13.6.1 Principia Biopharma Company Details
13.6.2 Principia Biopharma Business Overview and Its Total Revenue
13.6.3 Principia Biopharma Pemphigus Vulgaris Treatment Introduction
13.6.4 Principia Biopharma Revenue in Pemphigus Vulgaris Treatment Business (2015-2020)
13.6.5 Principia Biopharma Recent Development
13.7 Argenx
13.7.1 Argenx Company Details
13.7.2 Argenx Business Overview and Its Total Revenue
13.7.3 Argenx Pemphigus Vulgaris Treatment Introduction
13.7.4 Argenx Revenue in Pemphigus Vulgaris Treatment Business (2015-2020)
13.7.5 Argenx Recent Development
13.8 Alexion
13.8.1 Alexion Company Details
13.8.2 Alexion Business Overview and Its Total Revenue
13.8.3 Alexion Pemphigus Vulgaris Treatment Introduction
13.8.4 Alexion Revenue in Pemphigus Vulgaris Treatment Business (2015-2020)
13.8.5 Alexion Recent Development
13.9 Vifor Pharma
13.9.1 Vifor Pharma Company Details
13.9.2 Vifor Pharma Business Overview and Its Total Revenue
13.9.3 Vifor Pharma Pemphigus Vulgaris Treatment Introduction
13.9.4 Vifor Pharma Revenue in Pemphigus Vulgaris Treatment Business (2015-2020)
13.9.5 Vifor Pharma Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pemphigus Vulgaris Treatment Revenue
1.4 Market Analysis by Type
1.4.1 Global Pemphigus Vulgaris Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oral
1.4.3 Injectable
1.5 Market by Application
1.5.1 Global Pemphigus Vulgaris Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Pemphigus Vulgaris Treatment Industry Impact
1.6.1 How the Covid-19 is Affecting the Pemphigus Vulgaris Treatment Industry
1.6.1.1 Pemphigus Vulgaris Treatment Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Pemphigus Vulgaris Treatment Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Pemphigus Vulgaris Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Pemphigus Vulgaris Treatment Market Perspective (2015-2026)
2.2 Pemphigus Vulgaris Treatment Growth Trends by Regions
2.2.1 Pemphigus Vulgaris Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pemphigus Vulgaris Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Pemphigus Vulgaris Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Pemphigus Vulgaris Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Pemphigus Vulgaris Treatment Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Pemphigus Vulgaris Treatment Players by Market Size
3.1.1 Global Top Pemphigus Vulgaris Treatment Players by Revenue (2015-2020)
3.1.2 Global Pemphigus Vulgaris Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Pemphigus Vulgaris Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pemphigus Vulgaris Treatment Market Concentration Ratio
3.2.1 Global Pemphigus Vulgaris Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pemphigus Vulgaris Treatment Revenue in 2019
3.3 Pemphigus Vulgaris Treatment Key Players Head office and Area Served
3.4 Key Players Pemphigus Vulgaris Treatment Product Solution and Service
3.5 Date of Enter into Pemphigus Vulgaris Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Pemphigus Vulgaris Treatment Historic Market Size by Type (2015-2020)
4.2 Global Pemphigus Vulgaris Treatment Forecasted Market Size by Type (2021-2026)
5 PEMPHIGUS VULGARIS TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Pemphigus Vulgaris Treatment Market Size by Application (2015-2020)
5.2 Global Pemphigus Vulgaris Treatment Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Pemphigus Vulgaris Treatment Market Size (2015-2020)
6.2 Pemphigus Vulgaris Treatment Key Players in North America (2019-2020)
6.3 North America Pemphigus Vulgaris Treatment Market Size by Type (2015-2020)
6.4 North America Pemphigus Vulgaris Treatment Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Pemphigus Vulgaris Treatment Market Size (2015-2020)
7.2 Pemphigus Vulgaris Treatment Key Players in Europe (2019-2020)
7.3 Europe Pemphigus Vulgaris Treatment Market Size by Type (2015-2020)
7.4 Europe Pemphigus Vulgaris Treatment Market Size by Application (2015-2020)
8 CHINA
8.1 China Pemphigus Vulgaris Treatment Market Size (2015-2020)
8.2 Pemphigus Vulgaris Treatment Key Players in China (2019-2020)
8.3 China Pemphigus Vulgaris Treatment Market Size by Type (2015-2020)
8.4 China Pemphigus Vulgaris Treatment Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Pemphigus Vulgaris Treatment Market Size (2015-2020)
9.2 Pemphigus Vulgaris Treatment Key Players in Japan (2019-2020)
9.3 Japan Pemphigus Vulgaris Treatment Market Size by Type (2015-2020)
9.4 Japan Pemphigus Vulgaris Treatment Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Pemphigus Vulgaris Treatment Market Size (2015-2020)
10.2 Pemphigus Vulgaris Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pemphigus Vulgaris Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Pemphigus Vulgaris Treatment Market Size by Application (2015-2020)
11 INDIA
11.1 India Pemphigus Vulgaris Treatment Market Size (2015-2020)
11.2 Pemphigus Vulgaris Treatment Key Players in India (2019-2020)
11.3 India Pemphigus Vulgaris Treatment Market Size by Type (2015-2020)
11.4 India Pemphigus Vulgaris Treatment Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Pemphigus Vulgaris Treatment Market Size (2015-2020)
12.2 Pemphigus Vulgaris Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Pemphigus Vulgaris Treatment Market Size by Type (2015-2020)
12.4 Central & South America Pemphigus Vulgaris Treatment Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Roche
13.1.1 Roche Company Details
13.1.2 Roche Business Overview and Its Total Revenue
13.1.3 Roche Pemphigus Vulgaris Treatment Introduction
13.1.4 Roche Revenue in Pemphigus Vulgaris Treatment Business (2015-2020))
13.1.5 Roche Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview and Its Total Revenue
13.2.3 Novartis Pemphigus Vulgaris Treatment Introduction
13.2.4 Novartis Revenue in Pemphigus Vulgaris Treatment Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 GlaxoSmithKline
13.3.1 GlaxoSmithKline Company Details
13.3.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.3.3 GlaxoSmithKline Pemphigus Vulgaris Treatment Introduction
13.3.4 GlaxoSmithKline Revenue in Pemphigus Vulgaris Treatment Business (2015-2020)
13.3.5 GlaxoSmithKline Recent Development
13.4 Mylan
13.4.1 Mylan Company Details
13.4.2 Mylan Business Overview and Its Total Revenue
13.4.3 Mylan Pemphigus Vulgaris Treatment Introduction
13.4.4 Mylan Revenue in Pemphigus Vulgaris Treatment Business (2015-2020)
13.4.5 Mylan Recent Development
13.5 Genentech
13.5.1 Genentech Company Details
13.5.2 Genentech Business Overview and Its Total Revenue
13.5.3 Genentech Pemphigus Vulgaris Treatment Introduction
13.5.4 Genentech Revenue in Pemphigus Vulgaris Treatment Business (2015-2020)
13.5.5 Genentech Recent Development
13.6 Principia Biopharma
13.6.1 Principia Biopharma Company Details
13.6.2 Principia Biopharma Business Overview and Its Total Revenue
13.6.3 Principia Biopharma Pemphigus Vulgaris Treatment Introduction
13.6.4 Principia Biopharma Revenue in Pemphigus Vulgaris Treatment Business (2015-2020)
13.6.5 Principia Biopharma Recent Development
13.7 Argenx
13.7.1 Argenx Company Details
13.7.2 Argenx Business Overview and Its Total Revenue
13.7.3 Argenx Pemphigus Vulgaris Treatment Introduction
13.7.4 Argenx Revenue in Pemphigus Vulgaris Treatment Business (2015-2020)
13.7.5 Argenx Recent Development
13.8 Alexion
13.8.1 Alexion Company Details
13.8.2 Alexion Business Overview and Its Total Revenue
13.8.3 Alexion Pemphigus Vulgaris Treatment Introduction
13.8.4 Alexion Revenue in Pemphigus Vulgaris Treatment Business (2015-2020)
13.8.5 Alexion Recent Development
13.9 Vifor Pharma
13.9.1 Vifor Pharma Company Details
13.9.2 Vifor Pharma Business Overview and Its Total Revenue
13.9.3 Vifor Pharma Pemphigus Vulgaris Treatment Introduction
13.9.4 Vifor Pharma Revenue in Pemphigus Vulgaris Treatment Business (2015-2020)
13.9.5 Vifor Pharma Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Pemphigus Vulgaris Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Pemphigus Vulgaris Treatment Revenue
Table 3. Ranking of Global Top Pemphigus Vulgaris Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pemphigus Vulgaris Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral
Table 6. Key Players of Injectable
Table 7. COVID-19 Impact Global Market: (Four Pemphigus Vulgaris Treatment Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Pemphigus Vulgaris Treatment Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Pemphigus Vulgaris Treatment Players to Combat Covid-19 Impact
Table 12. Global Pemphigus Vulgaris Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Pemphigus Vulgaris Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Pemphigus Vulgaris Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Pemphigus Vulgaris Treatment Market Share by Regions (2015-2020)
Table 16. Global Pemphigus Vulgaris Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Pemphigus Vulgaris Treatment Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Pemphigus Vulgaris Treatment Market Growth Strategy
Table 22. Main Points Interviewed from Key Pemphigus Vulgaris Treatment Players
Table 23. Global Pemphigus Vulgaris Treatment Revenue by Players (2015-2020) (Million US$)
Table 24. Global Pemphigus Vulgaris Treatment Market Share by Players (2015-2020)
Table 25. Global Top Pemphigus Vulgaris Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pemphigus Vulgaris Treatment as of 2019)
Table 26. Global Pemphigus Vulgaris Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Pemphigus Vulgaris Treatment Product Solution and Service
Table 29. Date of Enter into Pemphigus Vulgaris Treatment Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Pemphigus Vulgaris Treatment Market Size by Type (2015-2020) (Million US$)
Table 32. Global Pemphigus Vulgaris Treatment Market Size Share by Type (2015-2020)
Table 33. Global Pemphigus Vulgaris Treatment Revenue Market Share by Type (2021-2026)
Table 34. Global Pemphigus Vulgaris Treatment Market Size Share by Application (2015-2020)
Table 35. Global Pemphigus Vulgaris Treatment Market Size by Application (2015-2020) (Million US$)
Table 36. Global Pemphigus Vulgaris Treatment Market Size Share by Application (2021-2026)
Table 37. North America Key Players Pemphigus Vulgaris Treatment Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Pemphigus Vulgaris Treatment Market Share (2019-2020)
Table 39. North America Pemphigus Vulgaris Treatment Market Size by Type (2015-2020) (Million US$)
Table 40. North America Pemphigus Vulgaris Treatment Market Share by Type (2015-2020)
Table 41. North America Pemphigus Vulgaris Treatment Market Size by Application (2015-2020) (Million US$)
Table 42. North America Pemphigus Vulgaris Treatment Market Share by Application (2015-2020)
Table 43. Europe Key Players Pemphigus Vulgaris Treatment Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Pemphigus Vulgaris Treatment Market Share (2019-2020)
Table 45. Europe Pemphigus Vulgaris Treatment Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Pemphigus Vulgaris Treatment Market Share by Type (2015-2020)
Table 47. Europe Pemphigus Vulgaris Treatment Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Pemphigus Vulgaris Treatment Market Share by Application (2015-2020)
Table 49. China Key Players Pemphigus Vulgaris Treatment Revenue (2019-2020) (Million US$)
Table 50. China Key Players Pemphigus Vulgaris Treatment Market Share (2019-2020)
Table 51. China Pemphigus Vulgaris Treatment Market Size by Type (2015-2020) (Million US$)
Table 52. China Pemphigus Vulgaris Treatment Market Share by Type (2015-2020)
Table 53. China Pemphigus Vulgaris Treatment Market Size by Application (2015-2020) (Million US$)
Table 54. China Pemphigus Vulgaris Treatment Market Share by Application (2015-2020)
Table 55. Japan Key Players Pemphigus Vulgaris Treatment Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Pemphigus Vulgaris Treatment Market Share (2019-2020)
Table 57. Japan Pemphigus Vulgaris Treatment Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Pemphigus Vulgaris Treatment Market Share by Type (2015-2020)
Table 59. Japan Pemphigus Vulgaris Treatment Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Pemphigus Vulgaris Treatment Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Pemphigus Vulgaris Treatment Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Pemphigus Vulgaris Treatment Market Share (2019-2020)
Table 63. Southeast Asia Pemphigus Vulgaris Treatment Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Pemphigus Vulgaris Treatment Market Share by Type (2015-2020)
Table 65. Southeast Asia Pemphigus Vulgaris Treatment Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Pemphigus Vulgaris Treatment Market Share by Application (2015-2020)
Table 67. India Key Players Pemphigus Vulgaris Treatment Revenue (2019-2020) (Million US$)
Table 68. India Key Players Pemphigus Vulgaris Treatment Market Share (2019-2020)
Table 69. India Pemphigus Vulgaris Treatment Market Size by Type (2015-2020) (Million US$)
Table 70. India Pemphigus Vulgaris Treatment Market Share by Type (2015-2020)
Table 71. India Pemphigus Vulgaris Treatment Market Size by Application (2015-2020) (Million US$)
Table 72. India Pemphigus Vulgaris Treatment Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Pemphigus Vulgaris Treatment Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Pemphigus Vulgaris Treatment Market Share (2019-2020)
Table 75. Central & South America Pemphigus Vulgaris Treatment Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Pemphigus Vulgaris Treatment Market Share by Type (2015-2020)
Table 77. Central & South America Pemphigus Vulgaris Treatment Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Pemphigus Vulgaris Treatment Market Share by Application (2015-2020)
Table 79. Roche Company Details
Table 80. Roche Business Overview
Table 81. Roche Product
Table 82. Roche Revenue in Pemphigus Vulgaris Treatment Business (2015-2020) (Million US$)
Table 83. Roche Recent Development
Table 84. Novartis Company Details
Table 85. Novartis Business Overview
Table 86. Novartis Product
Table 87. Novartis Revenue in Pemphigus Vulgaris Treatment Business (2015-2020) (Million US$)
Table 88. Novartis Recent Development
Table 89. GlaxoSmithKline Company Details
Table 90. GlaxoSmithKline Business Overview
Table 91. GlaxoSmithKline Product
Table 92. GlaxoSmithKline Revenue in Pemphigus Vulgaris Treatment Business (2015-2020) (Million US$)
Table 93. GlaxoSmithKline Recent Development
Table 94. Mylan Company Details
Table 95. Mylan Business Overview
Table 96. Mylan Product
Table 97. Mylan Revenue in Pemphigus Vulgaris Treatment Business (2015-2020) (Million US$)
Table 98. Mylan Recent Development
Table 99. Genentech Company Details
Table 100. Genentech Business Overview
Table 101. Genentech Product
Table 102. Genentech Revenue in Pemphigus Vulgaris Treatment Business (2015-2020) (Million US$)
Table 103. Genentech Recent Development
Table 104. Principia Biopharma Company Details
Table 105. Principia Biopharma Business Overview
Table 106. Principia Biopharma Product
Table 107. Principia Biopharma Revenue in Pemphigus Vulgaris Treatment Business (2015-2020) (Million US$)
Table 108. Principia Biopharma Recent Development
Table 109. Argenx Company Details
Table 110. Argenx Business Overview
Table 111. Argenx Product
Table 112. Argenx Revenue in Pemphigus Vulgaris Treatment Business (2015-2020) (Million US$)
Table 113. Argenx Recent Development
Table 114. Alexion Business Overview
Table 115. Alexion Product
Table 116. Alexion Company Details
Table 117. Alexion Revenue in Pemphigus Vulgaris Treatment Business (2015-2020) (Million US$)
Table 118. Alexion Recent Development
Table 119. Vifor Pharma Company Details
Table 120. Vifor Pharma Business Overview
Table 121. Vifor Pharma Product
Table 122. Vifor Pharma Revenue in Pemphigus Vulgaris Treatment Business (2015-2020) (Million US$)
Table 123. Vifor Pharma Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
Table 1. Pemphigus Vulgaris Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Pemphigus Vulgaris Treatment Revenue
Table 3. Ranking of Global Top Pemphigus Vulgaris Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pemphigus Vulgaris Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral
Table 6. Key Players of Injectable
Table 7. COVID-19 Impact Global Market: (Four Pemphigus Vulgaris Treatment Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Pemphigus Vulgaris Treatment Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Pemphigus Vulgaris Treatment Players to Combat Covid-19 Impact
Table 12. Global Pemphigus Vulgaris Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Pemphigus Vulgaris Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Pemphigus Vulgaris Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Pemphigus Vulgaris Treatment Market Share by Regions (2015-2020)
Table 16. Global Pemphigus Vulgaris Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Pemphigus Vulgaris Treatment Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Pemphigus Vulgaris Treatment Market Growth Strategy
Table 22. Main Points Interviewed from Key Pemphigus Vulgaris Treatment Players
Table 23. Global Pemphigus Vulgaris Treatment Revenue by Players (2015-2020) (Million US$)
Table 24. Global Pemphigus Vulgaris Treatment Market Share by Players (2015-2020)
Table 25. Global Top Pemphigus Vulgaris Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pemphigus Vulgaris Treatment as of 2019)
Table 26. Global Pemphigus Vulgaris Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Pemphigus Vulgaris Treatment Product Solution and Service
Table 29. Date of Enter into Pemphigus Vulgaris Treatment Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Pemphigus Vulgaris Treatment Market Size by Type (2015-2020) (Million US$)
Table 32. Global Pemphigus Vulgaris Treatment Market Size Share by Type (2015-2020)
Table 33. Global Pemphigus Vulgaris Treatment Revenue Market Share by Type (2021-2026)
Table 34. Global Pemphigus Vulgaris Treatment Market Size Share by Application (2015-2020)
Table 35. Global Pemphigus Vulgaris Treatment Market Size by Application (2015-2020) (Million US$)
Table 36. Global Pemphigus Vulgaris Treatment Market Size Share by Application (2021-2026)
Table 37. North America Key Players Pemphigus Vulgaris Treatment Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Pemphigus Vulgaris Treatment Market Share (2019-2020)
Table 39. North America Pemphigus Vulgaris Treatment Market Size by Type (2015-2020) (Million US$)
Table 40. North America Pemphigus Vulgaris Treatment Market Share by Type (2015-2020)
Table 41. North America Pemphigus Vulgaris Treatment Market Size by Application (2015-2020) (Million US$)
Table 42. North America Pemphigus Vulgaris Treatment Market Share by Application (2015-2020)
Table 43. Europe Key Players Pemphigus Vulgaris Treatment Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Pemphigus Vulgaris Treatment Market Share (2019-2020)
Table 45. Europe Pemphigus Vulgaris Treatment Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Pemphigus Vulgaris Treatment Market Share by Type (2015-2020)
Table 47. Europe Pemphigus Vulgaris Treatment Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Pemphigus Vulgaris Treatment Market Share by Application (2015-2020)
Table 49. China Key Players Pemphigus Vulgaris Treatment Revenue (2019-2020) (Million US$)
Table 50. China Key Players Pemphigus Vulgaris Treatment Market Share (2019-2020)
Table 51. China Pemphigus Vulgaris Treatment Market Size by Type (2015-2020) (Million US$)
Table 52. China Pemphigus Vulgaris Treatment Market Share by Type (2015-2020)
Table 53. China Pemphigus Vulgaris Treatment Market Size by Application (2015-2020) (Million US$)
Table 54. China Pemphigus Vulgaris Treatment Market Share by Application (2015-2020)
Table 55. Japan Key Players Pemphigus Vulgaris Treatment Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Pemphigus Vulgaris Treatment Market Share (2019-2020)
Table 57. Japan Pemphigus Vulgaris Treatment Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Pemphigus Vulgaris Treatment Market Share by Type (2015-2020)
Table 59. Japan Pemphigus Vulgaris Treatment Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Pemphigus Vulgaris Treatment Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Pemphigus Vulgaris Treatment Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Pemphigus Vulgaris Treatment Market Share (2019-2020)
Table 63. Southeast Asia Pemphigus Vulgaris Treatment Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Pemphigus Vulgaris Treatment Market Share by Type (2015-2020)
Table 65. Southeast Asia Pemphigus Vulgaris Treatment Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Pemphigus Vulgaris Treatment Market Share by Application (2015-2020)
Table 67. India Key Players Pemphigus Vulgaris Treatment Revenue (2019-2020) (Million US$)
Table 68. India Key Players Pemphigus Vulgaris Treatment Market Share (2019-2020)
Table 69. India Pemphigus Vulgaris Treatment Market Size by Type (2015-2020) (Million US$)
Table 70. India Pemphigus Vulgaris Treatment Market Share by Type (2015-2020)
Table 71. India Pemphigus Vulgaris Treatment Market Size by Application (2015-2020) (Million US$)
Table 72. India Pemphigus Vulgaris Treatment Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Pemphigus Vulgaris Treatment Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Pemphigus Vulgaris Treatment Market Share (2019-2020)
Table 75. Central & South America Pemphigus Vulgaris Treatment Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Pemphigus Vulgaris Treatment Market Share by Type (2015-2020)
Table 77. Central & South America Pemphigus Vulgaris Treatment Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Pemphigus Vulgaris Treatment Market Share by Application (2015-2020)
Table 79. Roche Company Details
Table 80. Roche Business Overview
Table 81. Roche Product
Table 82. Roche Revenue in Pemphigus Vulgaris Treatment Business (2015-2020) (Million US$)
Table 83. Roche Recent Development
Table 84. Novartis Company Details
Table 85. Novartis Business Overview
Table 86. Novartis Product
Table 87. Novartis Revenue in Pemphigus Vulgaris Treatment Business (2015-2020) (Million US$)
Table 88. Novartis Recent Development
Table 89. GlaxoSmithKline Company Details
Table 90. GlaxoSmithKline Business Overview
Table 91. GlaxoSmithKline Product
Table 92. GlaxoSmithKline Revenue in Pemphigus Vulgaris Treatment Business (2015-2020) (Million US$)
Table 93. GlaxoSmithKline Recent Development
Table 94. Mylan Company Details
Table 95. Mylan Business Overview
Table 96. Mylan Product
Table 97. Mylan Revenue in Pemphigus Vulgaris Treatment Business (2015-2020) (Million US$)
Table 98. Mylan Recent Development
Table 99. Genentech Company Details
Table 100. Genentech Business Overview
Table 101. Genentech Product
Table 102. Genentech Revenue in Pemphigus Vulgaris Treatment Business (2015-2020) (Million US$)
Table 103. Genentech Recent Development
Table 104. Principia Biopharma Company Details
Table 105. Principia Biopharma Business Overview
Table 106. Principia Biopharma Product
Table 107. Principia Biopharma Revenue in Pemphigus Vulgaris Treatment Business (2015-2020) (Million US$)
Table 108. Principia Biopharma Recent Development
Table 109. Argenx Company Details
Table 110. Argenx Business Overview
Table 111. Argenx Product
Table 112. Argenx Revenue in Pemphigus Vulgaris Treatment Business (2015-2020) (Million US$)
Table 113. Argenx Recent Development
Table 114. Alexion Business Overview
Table 115. Alexion Product
Table 116. Alexion Company Details
Table 117. Alexion Revenue in Pemphigus Vulgaris Treatment Business (2015-2020) (Million US$)
Table 118. Alexion Recent Development
Table 119. Vifor Pharma Company Details
Table 120. Vifor Pharma Business Overview
Table 121. Vifor Pharma Product
Table 122. Vifor Pharma Revenue in Pemphigus Vulgaris Treatment Business (2015-2020) (Million US$)
Table 123. Vifor Pharma Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Pemphigus Vulgaris Treatment Market Share by Type: 2020 VS 2026
Figure 2. Oral Features
Figure 3. Injectable Features
Figure 4. Global Pemphigus Vulgaris Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Pemphigus Vulgaris Treatment Report Years Considered
Figure 9. Global Pemphigus Vulgaris Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Pemphigus Vulgaris Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Pemphigus Vulgaris Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Pemphigus Vulgaris Treatment Market Share by Players in 2019
Figure 14. Global Top Pemphigus Vulgaris Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pemphigus Vulgaris Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Pemphigus Vulgaris Treatment Revenue in 2019
Figure 16. North America Pemphigus Vulgaris Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Pemphigus Vulgaris Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Pemphigus Vulgaris Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Pemphigus Vulgaris Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Pemphigus Vulgaris Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Pemphigus Vulgaris Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Pemphigus Vulgaris Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Roche Revenue Growth Rate in Pemphigus Vulgaris Treatment Business (2015-2020)
Figure 25. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Novartis Revenue Growth Rate in Pemphigus Vulgaris Treatment Business (2015-2020)
Figure 27. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. GlaxoSmithKline Revenue Growth Rate in Pemphigus Vulgaris Treatment Business (2015-2020)
Figure 29. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Mylan Revenue Growth Rate in Pemphigus Vulgaris Treatment Business (2015-2020)
Figure 31. Genentech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Genentech Revenue Growth Rate in Pemphigus Vulgaris Treatment Business (2015-2020)
Figure 33. Principia Biopharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Principia Biopharma Revenue Growth Rate in Pemphigus Vulgaris Treatment Business (2015-2020)
Figure 35. Argenx Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Argenx Revenue Growth Rate in Pemphigus Vulgaris Treatment Business (2015-2020)
Figure 37. Alexion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Alexion Revenue Growth Rate in Pemphigus Vulgaris Treatment Business (2015-2020)
Figure 39. Vifor Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Vifor Pharma Revenue Growth Rate in Pemphigus Vulgaris Treatment Business (2015-2020)
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed
Figure 1. Global Pemphigus Vulgaris Treatment Market Share by Type: 2020 VS 2026
Figure 2. Oral Features
Figure 3. Injectable Features
Figure 4. Global Pemphigus Vulgaris Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Pemphigus Vulgaris Treatment Report Years Considered
Figure 9. Global Pemphigus Vulgaris Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Pemphigus Vulgaris Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Pemphigus Vulgaris Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Pemphigus Vulgaris Treatment Market Share by Players in 2019
Figure 14. Global Top Pemphigus Vulgaris Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pemphigus Vulgaris Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Pemphigus Vulgaris Treatment Revenue in 2019
Figure 16. North America Pemphigus Vulgaris Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Pemphigus Vulgaris Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Pemphigus Vulgaris Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Pemphigus Vulgaris Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Pemphigus Vulgaris Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Pemphigus Vulgaris Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Pemphigus Vulgaris Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Roche Revenue Growth Rate in Pemphigus Vulgaris Treatment Business (2015-2020)
Figure 25. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Novartis Revenue Growth Rate in Pemphigus Vulgaris Treatment Business (2015-2020)
Figure 27. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. GlaxoSmithKline Revenue Growth Rate in Pemphigus Vulgaris Treatment Business (2015-2020)
Figure 29. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Mylan Revenue Growth Rate in Pemphigus Vulgaris Treatment Business (2015-2020)
Figure 31. Genentech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Genentech Revenue Growth Rate in Pemphigus Vulgaris Treatment Business (2015-2020)
Figure 33. Principia Biopharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Principia Biopharma Revenue Growth Rate in Pemphigus Vulgaris Treatment Business (2015-2020)
Figure 35. Argenx Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Argenx Revenue Growth Rate in Pemphigus Vulgaris Treatment Business (2015-2020)
Figure 37. Alexion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Alexion Revenue Growth Rate in Pemphigus Vulgaris Treatment Business (2015-2020)
Figure 39. Vifor Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Vifor Pharma Revenue Growth Rate in Pemphigus Vulgaris Treatment Business (2015-2020)
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed